
KBP-7018 hydrochloride
CAS No. 1613437-67-4
KBP-7018 hydrochloride( KBP 7018 hydrochloride | KBP7018 hydrochloride )
Catalog No. M12342 CAS No. 1613437-67-4
A novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 963 | Get Quote |
![]() ![]() |
50MG | 1962 | Get Quote |
![]() ![]() |
100MG | 2520 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameKBP-7018 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively.
-
DescriptionA novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively; also potently inhibits FLT3, VEGFR2, Fyn, PDGFRα and VEGFR2; shows promising outcomes for the treatments of idiopathic pulmonary fibrosis (IPF).
-
In Vitro——
-
In Vivo——
-
SynonymsKBP 7018 hydrochloride | KBP7018 hydrochloride
-
PathwayAngiogenesis
-
Targetc-Kit
-
Recptorc-Kit
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1613437-67-4
-
Formula Weight575.06
-
Molecular FormulaC31H31ClN4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC(=O)C1=CC2=C(C=C1)C(=C(N2)O)C(=NC3=CC4=C(C=C3)N(CC4)C(=O)CN5CCOCC5)C6=CC=CC=C6.Cl
-
Chemical NameMethyl (Z)-3-(((1-(2-morpholinoacetyl)indolin-5-yl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang Z, et al. ACS Med Chem Lett. 2017 Sep 30;8(11):1142-1147.
2. Huang Z, et al. Drug Des Devel Ther. 2015 Aug 5;9:4319-28.
molnova catalog



related products
-
CS-2660
CS-2660, a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.
-
AZD3229
AZD3229 (AZD-3229) is a potent, pan-KIT mutant inhibitor with potent single digit nM growth inhibition against a diverse panel of mutant KIT driven Ba/F3 cell lines (GI50=1-50 nM).
-
Bezuclastinib
Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.